Tan GD - Search Results

1

The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, Fielding BA, Karpe F. Tan GD, et al. Diabetologia. 2006 Jan;49(1):158-68. doi: 10.1007/s00125-005-0044-z. Epub 2005 Dec 17. Diabetologia. 2006. PMID: 16362285

2

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F. Tan GD, et al. Diabetologia. 2005 Jan;48(1):83-95. doi: 10.1007/s00125-004-1619-9. Epub 2004 Dec 24. Diabetologia. 2005. PMID: 15619071 Clinical Trial.

3

Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy.

Tan GD, Debard C, Funahashi T, Humphreys SM, Matsuzawa Y, Frayn KN, Karpe F, Vidal H. Tan GD, et al. Diabetologia. 2005 Aug;48(8):1585-9. doi: 10.1007/s00125-005-1835-y. Epub 2005 Jul 1. Diabetologia. 2005. PMID: 15991021 Clinical Trial.

4

Adipose tissue function in the insulin-resistance syndrome.

Karpe F, Tan GD. Karpe F, et al. Among authors: tan gd. Biochem Soc Trans. 2005 Nov;33(Pt 5):1045-8. doi: 10.1042/BST0331045. Biochem Soc Trans. 2005. PMID: 16246042 Review.

5

Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.

Tan GD, Olivecrona G, Vidal H, Frayn KN, Karpe F. Tan GD, et al. Diabetologia. 2006 Oct;49(10):2412-8. doi: 10.1007/s00125-006-0370-9. Epub 2006 Aug 1. Diabetologia. 2006. PMID: 16896939 Clinical Trial.

6

Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans.

Tan GD, Goossens GH, Humphreys SM, Vidal H, Karpe F. Tan GD, et al. Obes Res. 2004 Jan;12(1):114-8. doi: 10.1038/oby.2004.15. Obes Res. 2004. PMID: 14742849 Free article.

7

Fatty acid metabolism in patients with PPARgamma mutations.

Tan GD, Savage DB, Fielding BA, Collins J, Hodson L, Humphreys SM, O'Rahilly S, Chatterjee K, Frayn KN, Karpe F. Tan GD, et al. J Clin Endocrinol Metab. 2008 Nov;93(11):4462-70. doi: 10.1210/jc.2007-2356. Epub 2008 Aug 19. J Clin Endocrinol Metab. 2008. PMID: 18713822

8

Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.

Karpe F, Bickerton AS, Hodson L, Fielding BA, Tan GD, Frayn KN. Karpe F, et al. Among authors: tan gd. Biochem Soc Trans. 2007 Jun;35(Pt 3):472-6. doi: 10.1042/BST0350472. Biochem Soc Trans. 2007. PMID: 17511631 Review.

9

Adipose tissue: a key target for diabetes pathophysiology and treatment?

Frayn KN, Tan GD, Karpe F. Frayn KN, et al. Among authors: tan gd. Horm Metab Res. 2007 Oct;39(10):739-42. doi: 10.1055/s-2007-990270. Horm Metab Res. 2007. PMID: 17952837 Review.

10

Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.

Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, Chatterjee VK, Frayn KN, O'Rahilly S, Karpe F. Risérus U, et al. Among authors: tan gd. Diabetes. 2005 May;54(5):1379-84. doi: 10.2337/diabetes.54.5.1379. Diabetes. 2005. PMID: 15855323 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page